Acute lymphocytic leukemia in a patient with long-term carbamazepine exposure: Acute lymphoblastic leukemia that develops in a patient who has been using carbamazepine for a long time

Abstract

Introduction

Carbamazepine is an antiepileptic drug used in the treatment of epilepsy, trigeminal neuralgia, and bipolar disorder. Hematological effects that may develop with this anticonvulsant; agranulocytosis, thrombocytopenia, leukopenia, aplastic anemia, eosinophilia, or pancytopenia.

Case report

In this article, we wanted to present a case diagnosed with acute lymphoblastic leukemia after long-term use of carbamazepine because of epilepsy.

Management and outcome

Bone marrow smear was evaluated and blastic cell infiltration was observed. The carbamazepine treatment was discontinued and standard chemotherapy was started for acute lymphoblastic leukemia (CALGB protocol). Levetiracetam was started for epilepsy.

Discussion

Carbamazepine is an iminostilbene derivative. Carbamazepine is an antiepileptic drug that exhibits a number of side effects such as headache, abdominal pain, high blood pressure, as well as hematological disorders. In addition to causing thrombocytopenia, hypogammaglobulinemia, leukopenia, and neutropenia, it can have serious effects such as agranulocytosis, aplastic anemia, pure red cell aplasia, leukemia, or DRESS syndrome. The incidence of serious side effects from carbamazepine pharmacotherapy is low, and their exact mechanism of action is still unknown.

Keywords

Acute lymphoblastic leukemia carbamazepine cytopenia

Get full access to this article

View all access options for this article.

References

Flanagan

Dunk

. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol 2008; 23: 27–41.

Tutor-Crespo

Hermida

Tutor

. Relation of blood platelet count during carbamazepine and oxcarbazepine treatment with daily dose, and serum concentrations of carbamazepine, carbamazepine-10, 11-epoxide, and 10-hydroxycarbazepine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007; 151: 91–94.

Daughton

Padala

Gabel

. Careful monitoring for agranulocytosis during carbamazepine treatment. Prim Care Companion J Clin Psychiatry 2006; 8: 310–311.

Goyal

Bhandari

Rafi

. Long term carbamazepine therapy induced acute lymphoblastic leukemia. Int J Basic Clin Pharmacol 2013; 2: 222–223.

Nathan

Belsito

. Carbamazepine-induced pseudolymphoma with CD-30 positive cells. J Am Acad Dermatol 1998; 38: 806–809.

Yeo

Chow

Wong

, et al. Carbamazepine-induced lymphadenopathy mimicking Ki-1 (CD30+) T-cell lymphoma. Pathology 1997; 29: 64–66.

Allam

Paus

Reichel

, et al. DRESS Syndrome associated with carbamazepine and phenytoin. Eur J Dermatol 2004; 14: 339–342.

Di Lernia

Viglio

Cattania

, et al. Carbamazepine-induced, CD30+, primary, cutaneous, anaplastic large-cell lymphoma. Arch Dermatol 2001; 137: 675–676.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB